Download Citation
Article Source:
Three Main Mutational Pathways in HIV-2 Lead to High-Level Raltegravir and Elvitegravir Resistance: Implications for Emerging HIV-2 Treatment Regimens
Smith RA,
Raugi DN,
Pan C,
Coyne M,
Hernandez A,
et al.
(2012)
Three Main Mutational Pathways in HIV-2 Lead to High-Level Raltegravir and Elvitegravir Resistance: Implications for Emerging HIV-2 Treatment Regimens.
PLOS ONE 7(9): e45372.
https://doi.org/10.1371/journal.pone.0045372